Big Move For Catalyst Biosciences, Inc.
Mon, May 23, 2022 at 05:30 PM
Catalyst Biosciences, Inc. (CBIO:NASDAQ) rocketted at $1.27, representing a gain of 234.2%. The stock got featured on our News Catalysts scanner on Mon, May 09, 2022 at 10:40 AM in the 'EARNINGS' category. From Fri, May 06, 2022, the stock recorded 30.00% Up Days and 36.36% Green Days
About Catalyst Biosciences, Inc. (CBIO:NASDAQ)
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. The Company is engaged in creating and developing novel medicines to address serious medical conditions.
Top 10 Gainers:
- Catalyst Biosciences, Inc. (CBIO:NASDAQ), 234.21%
- Lixiang Education Holding Co. Ltd. (LXEH:NASDAQ), 58%
- View Inc. (VIEW:NASDAQ), 43.35%
- Predictive Oncology Inc. (POAI:NASDAQ), 40.74%
- Standard BioTools Inc Com (LAB:NASDAQ), 33.33%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 32.81%
- Evolving Systems, Inc. (EVOL:NASDAQ), 32.14%
- Neonode Inc. (NEON:NASDAQ), 28.8%
- O2Micro International Limited (OIIM:NASDAQ), 28.57%
- Sonder Holdings Inc. (SOND:NASDAQ), 27.43%